Cairn Biosciences
San Francisco, United States· Est. 2018
Cairn Biosciences discovers new medicines by mapping multiscale cell dynamics. Our proprietary COMPASS discovery platform unlocks exclusive routes to novel targets and drugs by navigating uncharted, complex and dynamic disease biology.
Private Company
Total funding raised: $11.1M
About
Cairn Biosciences discovers new medicines by mapping multiscale cell dynamics. Our proprietary COMPASS discovery platform unlocks exclusive routes to novel targets and drugs by navigating uncharted, complex and dynamic disease biology.
OncologyCell Therapy
Funding History
9Total raised:$11.1M
Grant$332KSep 20, 2021
Seed$5MJun 15, 2020
Grant$324KSep 13, 2019
Grant$822KAug 7, 2019